How does the research profile of pharma companies look like? What diseases are these companies investigating? What are their main research partners? Where are their laboratories and collaborators located? These are relevant questions for those interested on R&D dynamics in the pharmaceutical sector. However, this type of information is often not publicly available and, when it is available, it is often fragmented.
1. Find out about meta-science Have you ever wondered how science is organized and measured? If scientists are studying their own topics, then who are studying the scientists and the knowledge that they produced? We at the Centre for Science and Technology Studies (CWTS) are one of the few research centers in the world who study this.
The conference The impact of science is discussed in different formats and venues nowadays, and an example that stands out is the Impact of Science conference that was organised by the Network for Advancing and Evaluating the Societal Impact of Science (AESIS Network). The importance of impact of science becomes obvious, by taking into account, that this conference has been held six times before coming to
This week, as I was browsing the CWTS fields of science (as used for the Leiden Ranking), just for fun, I found a field with the following labels: Feminism Politic Queer theory Space Home There is something weird with these labels, I thought.
One of the most exciting developments in the past few years in the field of bibliometrics is the emergence of a number of important new data sources. Dimensions, created by Digital Science and made openly available for research purposes, is a prominent example. Other examples are Crossref and OpenCitations, which provide data that is fully open. The launch of Microsoft Academic in 2016 also represents a significant development.
Research efforts in health are well known to have unequal distributions: there is much more research on diseases more prevalent in rich countries than in diseases more prevalent in poorer countries. Why is this imbalance so persistent in spite of initiatives to support health research in the global south?